TGFB1 and cholangiocarcinoma: The fact that CCA evolves in a desmoplastic microenvironment, whereby TGFβ is extremely abundant and frequently associated with a poor prognosis, emphasizes the clinical relevance of TGFβ-targeted-therapies.